Dr. John Philip Schwerkoske, MD

  • Cerritos, CA
  • Hematologist and oncologist
NPI1912260829PAC ID3577785153
Medicare services, 2024
238
Medicare patients, 2024
86
Part D claims, 2024
1,716
Publications
2
Industry payments
$18,731
Practice address
18000 Studebaker Rd, Cerritos, CA 90703
Practice phone
Call (310) 945-8112
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

The Oncology Institute - Downey Radiation Oncology

Cerritos, California

See all 8 affiliations

Find Dr. Schwerkoske's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. John Philip Schwerkoske is a hematologist and oncologist in Cerritos, California

Dr. Schwerkoske practices at The Oncology Institute - Downey Radiation Oncology in Cerritos, California.

Dr. Schwerkoske's NPI, 1912260829, was assigned on June 17, 2012. Dr. Schwerkoske graduated from Creighton University School of Medicine - Omaha in 2012. Dr. Schwerkoske holds California license A136414.

NPI and contact details
Medicare PAC ID
3577785153
NPI enumeration date
June 17, 2012
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(310) 945-8112
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
40
Medical school graduation
2012

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. John Philip Schwerkoske practices at The Oncology Institute - Downey Radiation Oncology in Cerritos, California

Dr. Schwerkoske's primary practice is The Oncology Institute - Downey Radiation Oncology, at 18000 Studebaker Rd, Cerritos, CA 90703 in Los Angeles County. The practice phone is (310) 945-8112.

  • The Oncology Institute - Downey Radiation Oncology
    18000 Studebaker Rd, Cerritos, CA 90703 · Los Angeles CountyPhone(310) 945-8112

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. John Philip Schwerkoske is affiliated with 4 sites of care and 4 medical groups

Dr. Schwerkoske's primary practice is The Oncology Institute - Downey Radiation Oncology in Cerritos, California. The medical group on file is The Oncology Institute of Hope and Innovation. Dmand AI also links Dr. Schwerkoske to 3 more group practices and clinics and 3 medical groups, each named with a free account.

See all 8 affiliations for Dr. Schwerkoske

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. John Philip Schwerkoske's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwerkoske practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The Oncology Institute - Downey Radiation OncologyAvailable with a free account
+3 more sites and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Schwerkoske practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. John Philip Schwerkoske is one of 1,502 hematologists and oncologists in California

Hematology and oncology is Dr. Schwerkoske's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Schwerkoske is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Schwerkoske's licenses on file in 2 states: California and Minnesota.

Specialties and state licenses

  • Hematology and oncology, CaliforniaPrimaryLicense A136414 · 2015 to 2027 · taxonomy 207RH0003X
  • Minnesota license2014 to 2026

Clinical focus

Dmand AI lists breast cancer, chronic anemia, lung cancer, lymphoma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Schwerkoske treats.

Hematologists and oncologists near Dr. Schwerkoske

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. John Philip Schwerkoske billed Medicare for 238 services in 2024

CMS data shows 238 Medicare services from Dr. Schwerkoske across 4 procedure codes in 2024, for 86 Medicare patients. Medicare paid $21,567 for them. Every service was in an office.

Medicare services, 2024238
Medicare patients86
Paid by Medicare$21,567
Procedure codes4

Dr. Schwerkoske's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2102024: 12540%
Tests and treatments
2023: 2962024: 11362%
Drugs given in the office
2023: 1,3702024: 0100%
Surgery
2023: 302024: 0100%

Dr. Schwerkoske compared with the California median for hematologists and oncologists, 2024

  • Dr. Schwerkoske
  • California median
Medicare services
238vs 93274% below
Medicare patients
86vs 22562% below
Part D claims
1,375vs 3943.5 times

Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.

Dr. Schwerkoske's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Schwerkoske

Need commercial claims for Dr. Schwerkoske?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Schwerkoske and other hematologists and oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. John Philip Schwerkoske treated 86 Medicare patients in 2024, average age 71

CMS counts 86 Medicare patients who saw Dr. Schwerkoske in 2024. The largest group is 65 to 74, with 50 patients. 71% of them have high cholesterol, and 69% have high blood pressure. 34% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schwerkoske's median patient age at 69, with 61% women.

Medicare patients, 202486
Average age71
Average risk score2.03
Also on Medicaid34%

Dr. Schwerkoske's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Schwerkoske's Medicare patients by sex, 2024

  • Women5463%
  • Men3237%

Chronic conditions among Dr. Schwerkoske's Medicare patients, 2024

  1. High cholesterol71%
  2. High blood pressure69%
  3. Cancer51%
  4. Diabetes45%
  5. Arthritis43%
  6. Ischemic heart disease35%
  7. Chronic kidney disease31%
  8. Mood disorders26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Schwerkoske's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women61%
  • Men38%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. John Philip Schwerkoske wrote 1,716 Medicare Part D claims in 2024

In 2024, Dr. Schwerkoske wrote 1,716 Medicare Part D claims for 342 patients. 74% of them were for generic drugs. CMS names the drug for 1,375 of them, across 45 drugs with 11 or more claims each, at $3,653,533 in total drug cost. In 2023, CMS named 1,086 claims across 43 drugs.

Part D claims, 20241,716
Drugs named by CMS45
Total drug cost$3.7M
Part D patients342

Dr. Schwerkoske's Part D claims by kind of drug, 2024

  • Generic1,270 claims74%
  • Brand-name446 claims26%

Dr. Schwerkoske's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Schwerkoske's Part D claims, 2024

  • Opioids4%77 of 1,716 claims
  • Antibiotics1%21 of 1,716 claims
  • Antipsychotics, patients 65 and over1%17 of 1,716 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,0862024: 1,37527%

Drugs named by CMS: 45 in 2024, 43 in 2023.

See all prescribing by Dr. Schwerkoske

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. John Philip Schwerkoske offers telehealth to Medicare patients

Dr. Schwerkoske accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schwerkoske as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Schwerkoske by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. John Philip Schwerkoske has 2 publications on record

Dmand AI links 2 papers to Dr. Schwerkoske in 2012. Dr. Schwerkoske's most frequent co-authors are Paul D. Brown, MD, Jan C. Buckner, MD and Jason P. Caplan, MD.

Papers2

Dr. Schwerkoske's most frequent co-authors

Recent publications by Dr. Schwerkoske

See all 2 publications and co-authors

See who Dr. Schwerkoske researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Schwerkoske works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. John Philip Schwerkoske received $18,731 in industry payments from 2016 to 2025

CMS Open Payments shows 660 general payments to Dr. Schwerkoske from 77 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,327.

General payments to Dr. Schwerkoske by program year, 2016 to 2025

General payments to Dr. Schwerkoske by kind, 2016 to 2025

$18.7Kin total
  • Food and beverage$15,82885%
  • Device or supply loans$1,6629%
  • Education$1,2417%

Companies that paid Dr. Schwerkoske the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Schwerkoske

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. John Philip Schwerkoske graduated from Creighton University School of Medicine - Omaha

Dr. Schwerkoske graduated from Creighton University School of Medicine - Omaha in 2012.

  1. Medical schoolCreighton University School of Medicine - Omaha
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. John Philip Schwerkoske accepts plans from 17 insurance carriers

Dr. Schwerkoske is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.

Plan types Dr. Schwerkoske accepts, by number of carriers

  1. Medicare11
  2. PPO10
  3. HMO9
  4. POS5
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. John Philip Schwerkoske's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. John Philip Schwerkoske

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. John Philip Schwerkoske's NPI number?

Dr. John Philip Schwerkoske's NPI number is 1912260829. It was assigned on June 17, 2012, and it is active in the NPI Registry.

What kind of doctor is Dr. John Philip Schwerkoske?

Dr. John Philip Schwerkoske is a hematologist and oncologist in Cerritos, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. John Philip Schwerkoske practice?

Dr. Schwerkoske practices at 18000 Studebaker Rd, Cerritos, CA 90703. Dr. Schwerkoske's primary practice is The Oncology Institute - Downey Radiation Oncology in Cerritos, California. Dmand AI also links Dr. Schwerkoske to 3 group practices and clinics and 3 medical groups.

What is Dr. John Philip Schwerkoske's office phone number?

The practice phone on file for Dr. Schwerkoske is (310) 945-8112.

What is Dr. John Philip Schwerkoske's medical license number?

Dr. Schwerkoske holds California license A136414, one of the licenses on file in 2 states.

Which states has Dr. John Philip Schwerkoske been licensed in?

Dmand AI has state licenses on file for Dr. Schwerkoske in California (2015 to 2027) and Minnesota (2014 to 2026).

What medical group is Dr. John Philip Schwerkoske part of?

Dr. Schwerkoske is linked to The Oncology Institute of Hope and Innovation. Dmand AI links Dr. Schwerkoske to 3 more medical groups.

Does Dr. John Philip Schwerkoske accept Medicare?

Yes. CMS data shows Dr. Schwerkoske billed Medicare for 238 services in 2024, and Dr. Schwerkoske accepts Medicare assignment.

Does Dr. John Philip Schwerkoske offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Schwerkoske as offering telehealth services.

How many Medicare patients does Dr. John Philip Schwerkoske see?

CMS counts 86 Medicare patients who saw Dr. Schwerkoske in 2024, with an average age of 71.

Show 9 more questionsShow fewer questions

Is Dr. John Philip Schwerkoske board certified?

Yes. Dr. Schwerkoske is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. John Philip Schwerkoske bill to Medicare?

In 2024, Dr. Schwerkoske's most billed Medicare services were infusion or chemotherapy administration (96413), office visit, established patient (99214) and office visit, established patient (99213).

Where did Dr. John Philip Schwerkoske go to medical school?

Dr. Schwerkoske graduated from Creighton University School of Medicine - Omaha in 2012.

What drugs does Dr. John Philip Schwerkoske prescribe most?

In 2024 Medicare Part D data, Dr. Schwerkoske's most prescribed drugs by claims were Anastrozole, Letrozole and Alendronate Sodium.

Has Dr. John Philip Schwerkoske received payments from drug or device companies?

CMS Open Payments shows $18,731 in general payments to Dr. Schwerkoske from 77 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. John Philip Schwerkoske been practicing?

Dr. Schwerkoske graduated from medical school in 2012, 14 years ago.

Does Dr. John Philip Schwerkoske do research?

Dmand AI links 2 publications to Dr. Schwerkoske.

Who does Dr. John Philip Schwerkoske publish with?

Dr. Schwerkoske's most frequent co-authors are Paul D. Brown, MD (1 shared paper), Jan C. Buckner, MD (1 shared paper) and Jason P. Caplan, MD (1 shared paper).

What insurance does Dr. John Philip Schwerkoske accept?

Dr. Schwerkoske is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)